DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)

Phase 2

Completed

Conditions: Ovarian Cancer

Interventions: Drug: Paclitaxel
Drug: Carboplatin
Drug: Bevacizumab

First Posted Date: 2005-08-12

Last Posted Date: 2016-06-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 62

Registration Number: NCT00129727

A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder

Not Applicable

Completed

Conditions: Obsessive-Compulsive Disorder

First Posted Date: 2005-08-03

Last Posted Date: 2009-07-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 50

Registration Number: NCT00126282

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Anxiety Disorders Center, The Institute of Living, Hartford, Connecticut, United States

Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy

Phase 1

Completed

Conditions: Stress Disorders, Post-Traumatic

First Posted Date: 2005-07-21

Last Posted Date: 2014-06-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 60

Registration Number: NCT00121888

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature

Terminated

Conditions: Turner Syndrome
Idiopathic Short Stature

Interventions: Drug: somatropin (rDNA)

First Posted Date: 2005-07-21

Last Posted Date: 2009-09-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 1

Registration Number: NCT00121875

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight

Conditions: Fetal Growth Retardation

First Posted Date: 2005-07-18

Last Posted Date: 2011-07-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 12

Registration Number: NCT00120497

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder

Phase 4

Completed

Conditions: Post-Traumatic Stress Disorders

Interventions: Drug: Eszopiclone

First Posted Date: 2005-07-15

Last Posted Date: 2016-04-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 27

Registration Number: NCT00120250

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Pilot Study of Bupropion for Smoking Cessation in Postpartum Non-breastfeeding Women

Phase 4

Terminated

Conditions: Tobacco Use Disorder

Interventions: Other: placebo
Drug: Bupropion SR

First Posted Date: 2005-07-13

Last Posted Date: 2011-04-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT00119210

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Antibiotic Efficacy in Third Molar Surgery

Phase 3

Completed

Conditions: Alveolar Osteitis
Dry Socket
Infection

First Posted Date: 2005-07-12

Last Posted Date: 2010-07-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 132

Registration Number: NCT00118820

Locations: 🇺🇸
Outpatient Clinic for Oral and Maxillofacial Surgery, Wang Pavilion, ACC230, Boston, Massachusetts, United States

Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder

Not Applicable

Completed

Conditions: Attention Deficit Disorder With Hyperactivity

Interventions: Other: Relaxation techniques and education about ADHD
Behavioral: Cognitive behavioral therapy (CBT)

First Posted Date: 2005-07-12

Last Posted Date: 2018-01-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 86

Registration Number: NCT00118911

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Therapies for Treatment-Resistant Panic Disorder Symptoms

Phase 2

Completed

Conditions: Panic Disorder

Interventions: Drug: Clonazepam
Behavioral: Cognitive behavioral therapy
Drug: Sertraline

First Posted Date: 2005-07-11

Last Posted Date: 2014-06-11

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 46

Registration Number: NCT00118417

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy